To scan or not to scan: Use of transient elastography in an integrated health system

Table 1 Patient demographics

Characteristic	Pre-clinical decision support tool (n = 115)	Post-clinical decision support tool (n = 843)	P value
Age, year	58.3 ± 13.78	57.1 ± 14.02	0.3777
Female (%)	53.9	53.3	0.8956
Body mass index	31.6 ± 6.13	33.1 ± 7.10	0.0358
Race (%)			0.4486
African American	4.3	3.3
Asian	19.1	17.4
Hispanic	47.8	56.8
Non-Hispanic White	25.2	19.9
Other, unknown	3.5	2.5
Insurance plan type (%)			0.1312
Commercial, private pay	64.3	64.7
Dual	3.5	5.9
Medicaid	6.1	4.5
Medicare	24.3	24.7
Other, unknown	1.7	0.2
Medical Comorbidities (%)
Chronic hepatitis B	2.6	1.8	0.5415
Chronic hepatitis C	4.3	1.3	0.0172
Diabetes mellitus	45.2	42.4	0.5572
Hepatocellular carcinoma	0	0
Hyperlipidemia	52.2	58.6	0.1891
Liver transplant	0	0.4	0.5212
Obstructive sleep apnea	14.7	13.3	0.6662
Polycystic ovarian syndrome	1.7	0.5	0.1076
Primary biliary cholangitis	0.9	0.4	0.4242
Primary sclerosing cholangitis	0	0

Data are expressed as mean ± SD or n (%).